Epidaurus Health
Alexandria
About Epidaurus Health
Prior authorization is a bureaucratic bottleneck that costs the US healthcare system an estimated $35 billion per year, much of which is administrative waste. At Epidaurus Health, we’ve built a patent-protected SaaS solution to fix this inefficiency. Amphitheater, our modular, AI-powered platform, enables Pharmacy Benefit Managers (PBMs) to process more prior authorizations faster, with higher clinical accuracy, and at a lower cost’without losing the human touch. Amphitheater addresses a clear pain point in the PBM midmarket – our customers are struggling to scale without spiraling operational expenses. Midmarket PBMs are also hungry for AI, but remain wary of solutions that could compromise their member experience. Epidaurus Health bridges that gap in a unique way: - AI + Pharmacogenomics (PGx): We are working to be the first SaaS in our space to integrate genomic data to reliably predict medication efficacy. - Patented Federated AI: Context-aware AI adapts to each PBM’s pre-existing workflows without data leakage’a critical industry requirement. - Radically Faster Onboarding: Unlike competitors requiring 4-6 months to curate rules-based clinical scenarios, our AI-driven intake engine fully digitizes guidelines in minutes to help support the human decision-making process with more precision. - Proven Cost Savings: Our solution cuts time and cost by up to 50%, reducing the need for PharmDs to manually review every case.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.1M
- Funding stage: Seed
- Last round: Seed (Oct 2023)
- Website: epidaurus.health
- Phone: [email protected]
Industries & Categories
Health Care, Information Technology, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/epidaurus-health-36935 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.